The normoglycaemic biobreeding rat: a spontaneous model for impaired gastric accommodation by Vanormelingen, Christophe et al.
ORIGINAL ARTICLE
The normoglycaemic biobreeding rat: a spontaneous
model for impaired gastric accommodation
Christophe Vanormelingen,1 Tim Vanuytsel,1 Tatsuhiro Masaoka,1 Gert De Hertogh,2
Hanne Vanheel,1 Pieter Vanden Berghe,1 Ricard Farré,1 Jan Tack1
▸ Additional material is
published online only. To view
please visit the journal online
(http://dx.doi.org/10.1136/
gutjnl-2014-308154).
1Translational Research Center
for Gastrointestinal Disorders
(TARGID), University of Leuven,
Leuven, Belgium
2Department of Pathology,
University of Leuven, Leuven,
Belgium
Correspondence to
Professor Jan Tack,
Translational Research Center
for Gastrointestinal Disorders,
University of Leuven, Herestraat
49, Leuven 3000, Belgium;
Jan.Tack@med.kuleuven.be
Received 30 July 2014
Revised 17 October 2014
Accepted 22 October 2014
To cite: Vanormelingen C,
Vanuytsel T, Masaoka T,
et al. Gut Published Online
First: [please include Day
Month Year] doi:10.1136/
gutjnl-2014-308154
ABSTRACT
Objective Impaired gastric accommodation is reported
in patients with functional dyspepsia (FD). Previous
findings in postinfectious patients with FD suggest that
low-grade inflammation and dysfunction of nitrergic
nerves play a role in impaired accommodation. To date,
spontaneous animal models to study the relationship
between these changes are lacking. We hypothesise that
the normoglycaemic BioBreeding diabetes-prone (BB-DP)
rat provides an animal model of inflammation-induced
impaired gastric motor function.
Design Control diabetes-resistant biobreeding,
normoglycaemic and hyperglycaemic BB-DP rats were
sacrificed at the age of 30, 70 and 220 days and gastric
fundus tissue was harvested to study nitrergic motor
control, inflammation and expression of neuronal isoform
of nitric oxide synthase (nNOS) and inducible isoform of
nitric oxide synthase (iNOS). Nutrient-induced changes in
intragastric pressure (IGP) were measured in
normoglycaemic BB-DP rats to study accommodation.
Results No differences in nitrergic function and
inflammation were observed between BB-DP and control
rats at 30 days. The nitrergic component of the fundic
muscle relaxation was reduced in BB-DP rats of 70 and
220 days. This was accompanied by a significant loss of
nNOS proteins. IGP significantly increased during
nutrient infusion in BB-DP rats of 220 days, indicating
impaired accommodation. Infiltration of
polymorphonuclear cells, increased myeloperoxidase
activity and increased expression of iNOS was observed
in the fundic mucosa and muscularis propria of 70-day-
old and 220-day-old BB-DP rats.
Conclusions BB-DP rats of 220 days display altered
fundic motor control and impaired accommodation,
which is least partially explained by loss of nitrergic
function. This may be related to inflammatory changes in
the neuromuscular layer, suggesting that
normoglycaemic BB-DP rats provide a spontaneous
model for inflammation-induced impaired gastric
accommodation.
INTRODUCTION
Between meals, smooth muscle in the gastric
fundus maintains a high resting tone. Upon food
ingestion, a relaxatory response of the proximal
stomach occurs, allowing the storage of ingested
food without rise in intra-gastric pressure.1 This
gastric accommodation reflex is mediated by a
vago-vagal reflex and involves activation of nitrer-
gic neurons in the myenteric plexus of the proximal
stomach.2 Nitrergic neurons release nitric oxide
(NO) which induces muscle relaxation. Several
observations support a physiological role for the
gastric accommodation reflex in determining meal
volume and satiation.3 Moreover, impaired accom-
modation has been implicated in the pathogenesis
of symptoms in functional dyspepsia (FD), diabetic
gastropathy and post-Nissen dyspepsia.4–6
FD is a chronic gastrointestinal (GI) disorder
characterised by the occurrence of early satiation,
postprandial fullness and epigastric pain, in the
absence of abnormal findings at endoscopy or
other routine examinations.7 Impaired gastric
accommodation has been reported in
Significance of this study
What is already known on this subject?
▸ Several studies reported the presence of
low-grade mucosal inflammation in patients with
functional gastrointestinal disorders (FGID).
▸ There is evidence of inflammation at the level
of the enteric nervous system and nitrergic
dysfunction, being the underlying cause of an
impaired gastric accommodation in patients
with postinfectious functional dyspepsia.
▸ These observations suggest interactions between
acute inflammation, nitrergic dysfunction and
dysmotility in this patient group.
▸ To our knowledge, there are no spontaneous
animal models in which altered gastric
accommodation is studied and described.
What are the new findings?
▸ The normoglycaemic BioBreeding diabetes
prone (BB-DP) rat displayed an impaired gastric
accommodation which is partially caused by a
loss in nitrergic nervous function.
▸ This impaired accommodation is associated to
low-grade inflammation and loss of neuronal
isoform of nitric oxide synthase proteins which
develop over time in this model.
How might it impact on clinical practice in
the foreseeable future?
▸ The normoglycaemic BB-DP rat can help us to
understand the pathophysiological mechanisms
in patients with inflammation-induced impaired
gastric accommodation.
▸ This animal model might also be a useful tool
to develop new medications for patients
suffering from FGID.
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approximately 40% of patients suffering from FD.8 The mech-
anism underlying impaired accommodation in FD is incom-
pletely elucidated, but clinical and pharmacological observations
have implicated a role for low-grade inflammation and dysfunc-
tion of intrinsic nitrergic nerves. The prevalence of impaired
accommodation is high (70%) in patients with post-infectious
FD (PI-FD), and this can be attributed to impaired nitrergic
motor control of the proximal stomach.9 Patients with PI-FD
also maintain signs of ongoing low-grade inflammation up to
12 months after the initiating acute gastroenteritis on mucosal
biopsies, with increased number of neutrophils and mast cells,
the latter in close proximity to nerve fibres.10
These results suggest that dysfunction of nitrergic neurons is a
potential underlying cause for impaired gastric accommodation
and that this may be triggered by an inflammatory process. This
hypothesis is even more plausible, taking into account that infil-
tration of lymphocytes in the myenteric plexus of the small
intestine is associated to neuronal degeneration in patients with
IBS.11 Additionally, several studies in animal models with
induced inflammation in the small intestine showed an impaired
neuromuscular function which persists after the initial inflam-
mation and which was characterised by a loss of neuronal nitric
oxide synthase (nNOS) expression and a decrease in muscle
relaxation and in vivo contractility of the small intestine.12 13
Nevertheless, the mechanisms linking low-grade inflammatory
changes to impaired nitrergic motor control and decreased gastric
accommodation are poorly understood. One reason is the lack of a
spontaneous animal model of inflammation-related altered neur-
onal function and impaired accommodation. Recently, we identi-
fied the normoglycaemic BioBreeding diabetes prone (BB-DP) rat
as a potential model to study inflammation-induced altered intes-
tinal neuromotor function.14–16
The BB rat is an animal model that has been studied as a
model for human type 1 diabetes. This model consists of a
control BB-strain (control) and a diabetes-prone strain (BB-DP),
of which 50%–90% of the animals will eventually develop dia-
betes depending on their environment. A combination of pre-
diabetic changes in GI permeability, mucosal inflammation and
altered immune function seem to underlie the high prevalence
of autoimmune diseases such as diabetes in the diabetes-prone
strain.17 18 It has already been established that diabetic animals
show evidence of altered GI neuromuscular function, which has
been attributed to consequences of hyperglycaemia.19–21
Additionally, several changes in small intestinal neuromuscular
function were also reported in normoglycaemic BB-DP rats, includ-
ing ganglionic inflammation, loss of nNOS expression and nitrergic
function.16 Studies from our group have linked altered intestinal
motility to inflammatory changes in the myenteric plexus.13 To
date, it remains unclear whether similar events are also present in
other parts of the GI tract, including the proximal stomach.
The aim of this study was to evaluate whether the normogly-
caemic and hyperglycaemic BB-DP rats develop inflammation in
the neuromuscular layer, altered nitrergic nerve function and
impaired gastric accommodation. We, therefore, studied the
occurrence of inflammation, altered nNOS expression and
alterations in neuromuscular function in the proximal stomach
of these animals over time. Finally, the effect of these alterations
on gastric accommodation was tested in vivo.
MATERIALS AND METHODS
Animals
Breeding pairs of control, normoglycaemic and hyperglycaemic
diabetes-prone BB rats were obtained from the Animal
Resources Division of Health Canada (Ottawa, Ontario,
Canada) and further bred in the animal facility of the KU
Leuven, Belgium. Rats were housed in wire-meshed cages and
had ad libitum access to drinking water and standard rat chow.
Rats were sacrificed at different time points (30, 70 and
220 days) and tissue was harvested. Although our main focus
was to study the normoglycaemic diabetes-prone BB rats
(referred to as BB-DP in the remainder of the text), we also
added data from age-matched hyperglycaemic diabetes-prone
BB rats (referred to as BB-DPH in the remainder of the text) to
find out whether similar changes were present in our cohort.
Since diabetes developed in between 90 and 160 days of age, all
of our hyperglycaemic animals were sacrificed on day 220.
Experimental design
Previous experiments already showed that changes in the small
intestine were most pronounced at the age of 220 days.22 Based
on these findings, changes in intragastric pressure (IGP) during
infusion of a nutrient drink were measured in control and
BB-DP rats of 220 days old. IGP measurements in BB-DPH
animals were not feasible as these animals do not survive the
overnight fast that is required for this protocol.
Control and BB-DP rats of 30, 70 and 220 days and BB-DPH
rats of 220 days were sacrificed and their stomach was dissected
for further research. During dissection of the gastric fundus for
muscle strip experiments, fundic mucosa and neuromuscular
tissue was harvested for measurement of myeloperoxidase
(MPO) activity. The rest of the neuromuscular tissue was pre-
served for histology, MPO measurements and protein quantifica-
tion via western blot analysis.
IGP measurements
Gastric accommodation was assessed through measurements of
IGP during infusion of a nutrient drink via an implanted fistula
as previously described.23 During surgery, under isoflurane sed-
ation, an acryl plastic fistula was inserted into the stomach along
the major curvature, opposite to the oesophageal attachment in
the stomach. The fistula was then exteriorised through the left
abdominal muscle, making it possible to access the stomach
lumen from outside the animal. Animals were treated with
Baytril (enrofloxacin, Bayer) for 2 weeks in advance and during
the entire experiment in order to prevent infections. Rats were
also habituated to their restriction cages (Bollmann cages).
After an overnight fast, the rats were placed in Bollmann
cages and the fistula was connected to a custom-made infusion
system through which a preheated nutrient drink (Nutridrink,
Nutricia, Zoetmeer, The Netherlands; 630 kJ, 6 g proteins,
18.4 g carbohydrates and 5.8 g lipids per 100 mL) was infused.
In addition, a polyethylene catheter connected to an external
pressure transducer (DPT-6100, Pvb Medizintechnik;
Kirchseeon, Germany) was positioned into the stomach through
the fistula. IGP was recorded using WINDAQ recording soft-
ware (DataQ instruments). After a stabilisation period of
30 min, test-meal infusion into the stomach was started at a rate
of 30 mL/min for 20 min until a total volume of 10 mL was
infused. The NO inhibitor nitro-L-arginine methyl ester
(L-NAME) (30 mg/mL NaCl 0.9%) was given subcutaneously
15 min prior to the test meal infusion. L-NAME injection was
compared with a control condition where saline (0.9%) was
injected in the same animal. Changes in IGP were used as a
readout for gastric accommodation in the rat stomach as previ-
ously reported.23 Area under the curve (AUC) of the volume–
IGP curve was compared between the different strains and
experimental conditions.
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Relaxation experiments with smooth muscle strips
from the gastric fundus
The mucosa of the gastric fundus was removed and muscle strips
(length±10 mm, width 1.5 mm) were cut and suspended along
their circular axis in an organ bath filled with Krebs (120.9 mmol/L
NaCl, 2.0 mmol/L NaH2-PO4, 15.5 mmol/L NaHCO3, 5.9 mmol/
L KCl, 1.25 mmol/L CaCl2, 1.2 mmol/L MgCl2 and 11.5 mmol/L
glucose) solution held at 37°C and gassed with carbogen (95% O2/
5% CO2). After a 40 min equilibration period at a resting tension
of 1 g, acetylcholine 0.1 mmol/L was added to the organ bath to
measure maximal contraction. After a washout period of 30 min,
neuronal responses were elicited by electrical field stimulation
(EFS), applied via the two parallel platinum rod electrodes using a
Grass S88 stimulator (Grass, Guincy, Massachusetts, USA).
Frequency spectra (1–4 Hz) were obtained by pulse trains (pulse
0.35 ms, train 10 s, 8 V). The voltage was kept at 8 V by use of a
Med Lab Stimu-Splitter II (Med Lab, Loveland, Colorado, USA).
In between each pulse train, a 90 s recovery period was included.
The muscle activity was measured using an isometric force trans-
ducer/amplifier (Harvard Apparatus, South Natick, Massachusetts,
USA), recorded on a multirecorder and sampled for digital analysis
using the Windaq Data Acquisition system and a DI-2000 PGH
card (Dataq Instruments, Akron, Ohio, USA).
From then on all relaxatory responses induced by the EFS
spectrum were performed under non-adrenergic non-cholinergic
(NANC, presence of atropine 1 mmol/L and guanethidine
4 mmol/L) conditions. Precontraction was induced before each
spectrum by addition of substance P (SP) 1 mmol/L to the organ
bath, which generated a stable tone. Responses were charac-
terised pharmacologically by repeating the spectrum in the pres-
ence of L-NAME (0.3 mmol/L), which was added 15 min before
each EFS spectrum. Addition of L-NAME was used to study
alterations in the nitrergic component of the muscle relaxation.
Muscle responsiveness to NO was tested by addition of nitrogly-
cerine (NG) 10 mmol/L, immediately after the last EFS.
Similar to this protocol, an additional control experiment was
performed to compare the effect of the mucosal stripping on the
muscle contractility. Muscle strips with and without mucosa
coming from the same animal (three in total) were mounted in the
organ bath. Subsequently, we tested the muscle response to EFS in
the presence and absence of L-NAME as previously described.
The responses to EFS were calculated as the AUC during the
stimulation period (on-response) and corrected for the cross-
sectional area (g/(mm2 s)). The percentage decrease of electrical
induced muscle relaxation by L-NAME was calculated as
(Rbefore–Rafter)×100/Rbefore, where Rbefore and Rafter represent
the response before and after addition of the pharmaceutical
compound. This method was previously used by Smits et al.24
MPO activity
Fundic tissue was blotted dry, weighed and then minced on ice
in a potassium phosphate buffer (pH 7.4) containing 0.5% hex-
adecyltrimethylammoniumbromide (HTAB, Sigma Chemicals,
St. Louis, Missouri, USA). For further extraction, the tissue was
then homogenised for 4 min in the same buffer followed by two
freeze–thaw cycles. Samples were then centrifuged and 100 mL
of the supernatant was added to 2.9 mL of phosphate buffer
containing 0.53 mmol/L O-dianisidine and 0.15 mmol/L hydro-
gen peroxide (H2O2). The oxidation of the O-dianisidine is cat-
alysed by the peroxidase present in inflammatory cells, mainly
neutrophils. The change in absorbance at 460 nm was measured
every 30 s for 20 min in a spectrophotometer (Genesys 6,
Thermo LabSystems, Belgium). One unit of MPO activity was
defined as the amount of MPO activity required to convert
1 mmol of H2O2 to H2O per minute at 25°C, and activity was
presented as units per milligram of tissue.
Histology and immunohistochemistry
Transmural fundic tissue (±15 mm2 surface area) was fixed in 4%
neutral-buffered formalin, embedded in paraffin and stained with
standard H&E. The biopsies were checked for mucosal damage
(presence of erosions or ulcers) and then evaluated for numbers of
polymorphonuclear (PMN) cells in the submucosa (total amount
of PMN cells per 10 high-power fields (HPF),=×400 magnifica-
tion). The infiltration of PMN cells in the myenteric plexus was
also quantified by counting the PMN cells present in the ganglia.
Counts were performed by a single experienced pathologist
(GDH) who was not informed on animal treatment, symptoms or
other experimental data. Connective tissue mast cells were
observed after toluidine blue staining and quantified by counting
10 HPF at the intramuscular level (×400 magnification).
RT-PCR analysis
RT-PCR was performed using a Lightcycler 480 (Roche Applied
Science, Penzberg, Germany). LightCycler 480 SYBR Green 1
Master Mix (Roche Applied Science) was combined with cDNA
samples and primers for nNOS and iNOS (forward:
ACCCAAGGTCTACGTTCAAGACA; reverse: CACATCCCG
AGCCATGC) from TIB molbiol, Berlin, Germany. Different
50-splice variants of nNOS have been reported by other groups,
PCR was performed on nNOSα (three different splice variants
nNOSα-a, nNOSα-b and nNOSα-c) and nNOSβ (primer design
based on previous literature).25 Expression was normalised to the
hypoxanthine phosphoribosyltransferase gene, and results are pre-
sented as fold change as described previously.26
Western blot analysis
Fundic neuromuscular tissue was dissected and snap-frozen in
liquid nitrogen and stored at −80°C. Frozen tissue was homoge-
nised in lysis buffer (Tissue Protein Extraction Reagent) and phos-
phatase inhibitor cocktail (Thermo Fisher Scientific, Rockford,
Illinois, USA). After centrifugation, the total protein concentration
was determined. Equal amounts of protein (25 mg) were run on a
4%–12% gradient sodium dodecyl sulfate-polyacrylamide gels
(Invitrogen, Carlsbad, California, USA) and then transferred to
polyvinylidene difluoride membranes. After blocking with dried
milk dissolved in TBS-T buffer (Tris-Buffered Saline and Tween
20), blots were incubated overnight at 4°C with the primary anti-
bodies rabbit anti-nNOS (1/200, Santa Cruz Biotechnology, Santa
Cruz, California, USA), iNOS (1/200, Abcam, Cambridge, UK),
the general neuronal marker: rabbit anti-PGP9.5 (1/500, Merck
Millipore, Darmstadt, Germany) and rabbit antiglyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (1/500, Abcam, Cambridge,
UK). Then blots were incubated for 2 h at room temperature with
the horseradish peroxidase-conjugated secondary antibodies raised
against rabbit immunoglobulin G. Bands were visualised by incu-
bating the blot for 5 min in Supersignal West Femto Maximum
Sensitivity Substrate (Thermo Fisher Scientific, Doornveld,
Belgium). After scanning, bands were quantified by densitometry
using Image J software (National Institutes of Health; http://rsb.
info.nih.gov.ij/). Expression of PGP9.5 was quantified relative to
the housekeeping protein GAPDH. The total amount of nNOS
protein was expressed relatively to PGP9.5.
Statistical analysis
Data are expressed as mean±SEM, with ‘n’ indicating the
number of rats. Analysis of the in vitro contractility data was
Vanormelingen C, et al. Gut 2014;0:1–9. doi:10.1136/gutjnl-2014-308154 3
Stomach
group.bmj.com on January 13, 2015 - Published by http://gut.bmj.com/Downloaded from 
done with SAS for Microsoft Windows, V.9.2 (SAS Institute,
Cary, North Carolina, USA). Control and BB-DP groups were
compared with a mixed model analysis (proc mixed). Strain
(BB-DP and control), frequency of EFS (1–4 Hz) and a strain by
frequency interaction term were entered in the model as fixed
effects. EFS frequency was also included as a repeated effect.
Analysis of all other data was performed using Graphpad soft-
ware (Graph Pad Software, San Diego, California, USA).
Differences between two groups were tested by two-tailed
unpaired Student t test or Mann–Whitney U test depending on
the distribution of the data, which was checked by a
Kolmogorov–Smirnov test. Differences between more than two
groups were evaluated by analysis of variance with post hoc
t test and Bonferroni correction for multiple testing or Kruskal–
Wallis test with Dunn’s multiple comparison test when appropri-
ate. Results were considered significant with p value <0.05.
RESULTS
Gastric accommodation
Changes in IGP during nutrient infusion in the stomach of
220-day-old rats were used as a readout for gastric accommoda-
tion to the infused liquid meal, with higher pressures reflecting
impaired accommodation.23 The IGP during nutrient infusion
in BB-DP rats was significantly higher compared with age-
matched control rats (AUC during nutrient infusion: 105.8±5.7
vs 80.3±8.8 mL × mmHg, p<0.05) (figure 1A). The effect of
L-NAME treatment on IGP changes in BB-DP and control
animals was compared with saline treatment in the same
animals. This was done to evaluate whether the difference in
IGP between both animal groups could be attributed to
impaired nitrergic function. A significant increase of the IGP
occurred when control animals were treated with L-NAME
(AUC 68.9±7.7 vs 116.4±13.8 mL × mm Hg, p<0.01)
(figure 1A). In contrast, the IGP in BB-DP animals of 220 days
did not change when treated with L-NAME (AUC 105.8±5.7
vs 98.1±11.0). There were no significant differences when com-
paring the IGP of L-NAME-treated control rats with saline-
treated BB-DP rats. The total stomach weight was comparable
between both groups. Together, these data demonstrate
impaired accommodation in the BB-DP BB-rat, which is at least,
in part, attributable to loss of nitrergic neuronal function. The
onset of nitrergic dysfunction was studied using muscle strip
studies at variable ages.
Neuromuscular function of the gastric fundus
EFS-induced muscle strip relaxation under NANC conditions
was comparable in 30-day-old and 70-day-old BB-DP and
control rats (figure 2A, B). At the age of 220 days, relaxation
over all frequencies was significantly impaired in BB-DP and
BB-DPH rats (p<0.05) (figure 2C). Both contraction induced
by SP and the total percentage of relaxation induced by NG
were the same in all animal groups at all time points, indicating
that there were no differences in contractile and relaxatory cap-
abilities of the muscle.
To evaluate potential differences in nitrergic contribution to
the muscle relaxation, the L-NAME-induced reduction in
muscle relaxation under NANC conditions was calculated.
There were no differences in nitrergic contribution at the age of
30 days. In contrast, the nitrergic contribution to the muscle
relaxation was significantly smaller in 70-day-old and
220-day-old BB-DP and BB-DPH rats (figure 3).
Control experiments showed that muscle relaxation and the
effect of L-NAME on the relaxation was similar when compar-
ing muscle strips with and without mucosal tissue. This confirms
that removal of the mucosa has no relevant effect on the muscle
strip function (see online supplementary figure S1).
MPO activity in the gastric fundus
MPO activity was measured in the mucosa and neuromuscular
layer of control animals and compared with age-matched BB-DP
rats. Mucosal MPO activity at 30 days was negligible and similar
in both strains (0.01±0.0 vs 0.0±0.0 U/mg; p=0.2). In contrast,
MPO activity in the mucosa of BB-DP rats was significantly
increased at 70 days (1.10±0.04 vs 0.03±0.01 U/mg, p<0.01)
and in BB-DP and BB-DPH rats of 220 days (control, 0.02
±0.01 vs BB-DP, 0.63±0.40, p<0.01 and BB-DPH, 0.68
Figure 1 In vivo measurement of
intragastric pressure (IGP) changes. (A)
Area under the curve (AUC) of the
pressure–volume curve during nutrient
drink infusion. Comparison between
control (black bars) and BioBreeding
diabetes-prone (BB-DP) (white bars)
animals was done under saline and
nitro-L-arginine methyl ester (L-NAME)
treatment. (B) Individual tracing of
control animals. (C) Individual tracing
of BB-DP rats. (D) Representative
tracing of IGP changes by infusion of
nutrient drink comparing
L-NAME-treated control animals with
BB-DP rats under control conditions.
**p<0.01 control saline versus control
L-NAME and γp<0.05 control saline
versus BB-DP saline.
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±0.25 U/mg, p<0.05) (figure 4A). This was also the case when
MPO activity was measured in the neuromuscular layer of
BB-DP rats at 70 days (BB-DP, 0.85±0.70 vs 0.01±0.01 U/mg,
p<0.01) and in BB-DP and BB-DPH rats of 220 days (control,
0.01±0.005 vs BB-DP, 1.00±0.28, p<0.01 and BB-DPH, 0.58
±0.32 units/mg, p<0.01) (figure 4B).
PMN infiltration in the submucosa and myenteric ganglia
None of the animals displayed any erosions or damage at the
mucosal and muscular level when evaluating the gastric fundus
macroscopically and microscopically. Absence of PMN cells in
the mucosa and myenteric ganglia of both BB-DP and control
rats at the age of 30 days confirmed that there was no inflamma-
tion at this time point. There was, however, a significant
increase of PMN cells in the submucosa of 70-day-old and
220-day-old BB-DP and 220-day-old BB-DPH rats compared
with age-matched control animals (figure 5A, C, E). The
amount of PMN cells in the myenteric ganglia was also signifi-
cantly increased in BB-DP rats of 70 and 220 days and BB-DPH
rats of 220 days (figure 5B, D, F).
The total amount of connective tissue mast cells was signifi-
cantly increased at 70 (3.7±2.7 vs 27.2±14.2/10 HPF, p<0.05)
and 220 days (control, 3.3±1.8 vs BB-DP, 58.6±13.2, p<0.01
and BB-DPH 10.4±2.7/10 HP, p<0.01) in BB rats, but no dif-
ferences were found at the age of 30 days.
To investigate whether there is a direct relationship between
inflammatory changes and altered gastric function, IGP values
of BB-DP rats were correlated with the levels of MPO activity
and the amount of PMN cells. Both MPO activity (r²=0.39)
and amount of PMN cells (r²=0.089) did not significantly cor-
relate with the IGP values of the BB-DP animals.
nNOS and iNOS mRNA expression in the neuromuscular
layer of the gastric fundus
Expression of iNOS and nNOS splice variants was not altered
when comparing control rats with both BB-DP and BB-DPH
rats. Expression data are summarised in table 1.
nNOS and iNOS protein expression in the neuromuscular
layer of the gastric fundus
The amount of nNOS protein in the neuromuscular layer was
expressed relative to the general neuronal marker PGP9.5. No
differences in GAPDH and PGP9.5 expression were found at
any time point, suggesting that the total amount of neurons was
largely preserved. nNOS protein expression did not differ when
comparing BB-DP with control rats at the ages of 30 and
70 days (figure 6A, B). In contrast, a significant loss of both
nNOS and a significant increase of iNOS protein expression
occurred in BB-DP (p<0.01 and <0.05) and BB-DPH rats
(p<0.01 and <0.05) at the age of 220 days (figure 6C). No sig-
nificant difference was found when comparing nNOS and iNOS
protein expression between BB-DP and BB-DPH rats.
DISCUSSION
Clinical observations and pathophysiological studies suggest that
dyspeptic symptoms and impaired gastric accommodation may
occur as a consequence of GI inflammation, leading to impaired
nitrergic nerve function in the proximal stomach. Unravelling
the pathophysiological cascade underlying these events would
benefit from the availability of a spontaneous animal model of
impaired accommodation and gastric nitrergic dysfunction. In
the present study, we demonstrated the occurrence of increased
inflammation in the gastric fundus of the normoglycaemic
BB-DP rat, followed by impaired nitrergic motor control and
decreased expression of nNOS protein. This was accompanied
by impaired gastric accommodation, which was at least, in part,
attributable to a loss of muscle relaxation induced by the nitrer-
gic neurons. In addition, we found that the same alterations
were present in the BB-DPH rat, which is in line with the previ-
ous observations in hyperglycaemic BB rats.20
Previous studies have reported inflammatory changes in the GI
tract of the BB-DP rat. Early data found a marked inflammatory
infiltrate in the colon of these animals, both in the muscularis and
the enteric ganglia.27 Also in the small bowel of these animals,
increased MPO activity was reported, which increased over
time.28 Based on these findings, we studied the occurrence of
inflammation in the gastric fundus from control, BB-DP and
BB-DPH animals at several time points and measured MPO and
Figure 2 Measurement of EFS-induced muscle relaxation under
non-adrenergic, non-cholinergic conditions. Fundic muscle strips were
incubated with atropine and guanethidine 15 min before precontraction
with substance P. Muscle strip relaxation was induced by EFS
stimulation at four different frequencies. Relaxation values were
expressed as area under the curve (AUC), which was corrected by the
cross-sectional area. Statistical analysis was done by a mixed model
analysis, where the main effect of group was studied at the three
different ages (N: 6–7; (A) 30 days; (B) 70 days; (C) 220 days). BB-DP,
BioBreeding diabetes-prone; BB-DPH, hyperglycaemic diabetes-prone
BB rats; EFS, electrical field stimulation.
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PMN cell infiltrates in the mucosa and muscle layer of this tissue.
We found an increase of the total MPO activity in the mucosa and
neuromuscular layer of the proximal stomach of BB-DP rats at 70
and 220 days of age in contrast to very little MPO activity at the
age of 30 days. The inflammatory changes measured by MPO
were confirmed by increased numbers of PMN cells in the sub-
mucosa and enteric ganglia. This was accompanied by a signifi-
cantly increased amount of mast cells within the circular and
longitudinal muscle layer at these time points. In addition, also
hyperglycaemic animals displayed an increase of MPO activity and
PMN cells, which was comparable with the values in their normo-
glycaemic counterparts. The absence of a significant difference
between normoglycaemic and hyperglycaemic animals suggests
that the inflammatory changes in the diabetic cohort are most
likely not caused by the hyperglycaemic state. Nevertheless, we
cannot exclude that the hyperglycaemic state also contributes to
the severity of these conditions, but addressing this issue was
beyond the scope of this study. The findings in BB-DP animals are
reminiscent of some of the alterations found in antral biopsies of
patients with paediatric FD, where an increase in mucosal mast
cell counts was significantly correlated with disordered motility.29
The type of inflammation qualifies as low-grade inflammation as
no scar tissue or macroscopic mucosal lesions were found in the
gastric fundic biopsies of these animals.
Previous data from a trinitrobenzenesulfonic acid-induced rat
model showed that inflammation can lead to impaired nitrergic
function of the enteric nervous system in the small intestine.13
In this model, small intestinal motility was disrupted by the loss
of nNOS protein expression as a consequence of the local
inflammation. In the present study, muscle strip experiments
were performed in the absence and presence of L-NAME at dif-
ferent time points. No differences in nitrergic function were
found at 30 days, but BB rats of 70 and 220 days of age had
impaired nitrergic relaxation, and this was associated with a sig-
nificantly decreased total relaxation at 220 days.
Western blot analysis confirmed decreased expression of
nNOS in the proximal stomach in BB-DP animals at 220 days
but not at 30 and 70 days. Although nNOS expression is not
altered at the age of 70 days, we did find an impaired nitrergic
relaxation at this time point. This could be explained by the fact
that inflammatory alterations can already impair nNOS function
without a loss of the nNOS protein.30 Previous data showed
that an increased expression of iNOS caused by alterations in
inflammatory state correlated with the decreased expression of
Figure 3 Nitrergic contribution to
the muscle relaxation. Fundic muscle
strips were incubated with atropine,
guanethidine and nitro-L-arginine
methyl ester (L-NAME) for 15 min
before precontraction with substance
P. Muscle strip relaxation was induced
as previously mentioned. Delta
L-NAME was calculated by subtracting
relaxatory values of each strip under
non-adrenergic, non-cholinergic
(NANC) from NANC+L-NAME
conditions, after which this delta was
expressed as percentage of the
relaxation under NANC conditions.
Statistical analysis was done by a
mixed model analysis, where the main
effect of group, comparing control
(black dots), BioBreeding
diabetes-prone (BB-DP) (white dots)
and hyperglycaemic diabetes-prone BB
rats (BB-DPH) (white triangles)
conditions, was studied at the three
different ages (N: 6–7; (A) 30 days;
(B) 70 days; (C and D) 220 days).
Figure 4 Myeloperoxidase (MPO) activity in mucosa and muscular layer of the gastric fundus. MPO activity is expressed in units per milligram of
tissue. MPO was measured both in mucosal (A) and muscle (B) tissue and a comparison was made between control (black bars; N: 5-6),
BioBreeding diabetes-prone (BB-DP) (white bars; N: 6–7) and hyperglycaemic diabetes-prone BB rats (BB-DPH) (grey bars; N: 7) done within age
match groups. *p<0.05, **p<0.01, ***p<0.001.
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Figure 5 Histological evaluation and quantification of inflammatory changes in fundic tissue. Histological evaluation and quantification of
polymorphonuclear (PMN) cells was done in H&E-stained tissue. The total amount of PMN cells in the mucosa (A) was quantified in 10 high-power fields
(10×60) by a single experienced pathologist. The amount of PMN in the ganglia (B) is expressed as cells per ganglion. Comparison between control (black
bars; N: 5–7), BioBreeding diabetes-prone (BB-DP) (white bars; N: 5–7) and hyperglycaemic diabetes-prone BB rats (BB-DPH) (grey bars, N: 6) was done
within age match groups. *p<0.05, ***p<0.001. Representative pictures of both control (C) and BB-DP (D) rats of 220 days of age are shown after an H&E
staining. Detailed picture of ganglion from control (E) and BB-DP (F) rats, with the presence of PMN cells in the ganglion of the BB-DP rats.
Table 1 Gene expression of neuronal and inducible NOS
Age (days) Gene Control BB-DP p Value BB-DPH p Value
70 nNOS-α a 1±0.39 1.85±1.35 P=0.4
nNOS-α b 1±0.31 2.10±1.11 P=0.4
nNOS-α c 1±0.12 3.74±1.85 P=0.3
nNOS-β 1±0.36 1±0.78 P=0.8
iNOS 1±0.12 1.18±0.34 P=0.9
220 nNOS-α a 1±0.12 0.73±0.37 P=0.6 0.86±0.13 P=0.4
nNOS-α b 1±0.16 0.76±0.34 P=0.8 0.55±0.11 P=0.1
nNOS-α c 1±0.25 0.87±0.33 P=0.9 1.09±0.23 P=0.8
nNOS-β 1±0.93 2.40±2.48 P=0.1 2.17±0.49 P=0.2
iNOS 1±0.23 2.5±1.4 P=0.2 1.39±3.5 P=0.9
Gene expression of nNOS splice variants (nNOSα and nNOSβ) and iNOS was measured in control, BB-DP and BB-DPH rats of 70 and 220 days (n=6) by the use of real-time reverse
transcriptase PCR. Data were normalised to the housekeeping gene, hypoxanthine phosphoribosyltransferase and expressed as fold change. Data in this table represent the fold change
of BB-DP and BB-DPH rats, which is compared with a fold change of one in control rats.
BB-DP, BioBreeding diabetes prone; BB-DPH, hyperglycaemic diabetes-prone BB rats; nNOS, neuronal isoform of nitric oxide synthase; iNOS, inducible isoform of nitric oxide synthase.
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nNOS in animal models with colitis.31 We found a significant
increase of the iNOS protein levels in both BB-DP and BB-DPH
rats, which is likely to be caused by the local inflammation.
Increased iNOS levels could partly explain the loss of the nNOS
protein, which is underlying to the impaired gastric function.
In contrast to the expression at protein level, mRNA expression
of both nNOS and iNOS was not significantly altered in our
model, suggesting that changes occur mainly at the translational
level. Although we cannot exclude that regulation at transcrip-
tional and post-transcriptional level is altered, several mechanisms
have been suggested by which iNOS and nNOS are increased at
the protein but remain unaltered at the mRNA level. Previous data
already showed that nNOS has a complex transcriptional regula-
tion and several mRNA splice variants will translate into the same
nNOS protein.25 Additionally, antisense RNA transcripts, RNA
binding proteins and proteasomal activity can alter the amount of
nNOS and iNOS protein expression.32–34
Both inflammatory changes and loss of nNOS are absent at
the age of 30 days, which explains why nitrergic function is not
yet impaired in these animals. At more advanced time points,
both inflammatory changes and loss of nitrergic neurons are
present and these probably represent the underlying cause for
the impaired muscle function observed in the stomach.
There were no differences in PGP9.5 expression between
both groups at all time points, suggesting that the total amount
of neurons was preserved and argues against a non-specific neur-
onal damage caused by the inflammatory changes.
Kang et al35 described a rat model with impaired accommodation
and gastric hypersensitivity after induction of gastric ulcers by injec-
tion of acetic acid in the stomach. Both mucosa and muscularis
propria surrounding these ulcers were damaged, but no differences
in muscle contractility were found. Although behavioural changes
indicated an increased amount of discomfort and pain when accom-
modation was induced, changes were only described within 14 days
after ulcer induction. Experiments from another research group
showed that also gastric irritation with iodoacetamide in the neo-
natal period caused increased gastric sensitivity and impaired
accommodation 8–10 weeks after induction.36 Both studies
confirm that changes in gastric function can be mimicked in animal
models and that inflammation can have an acute or long-term effect
on gastric function. However, these models of induced damage or
toxicity are less likely to reflect the clinical picture of postinfectious
impaired accommodation observed in FD in humans.
In keeping with the established role of nitrergic nerves in the
proximal stomach in mediating gastric accommodation, we
demonstrated the presence of impaired gastric accommodation in
normoglycaemic BB-DP rats. We presume that this defect was
attributable to a loss of nitrergic control at the level of the gastric
fundus since there was no inhibitory effect of L-NAME on accom-
modation. Delayed gastric emptying is unlikely to play a role in
this observation since this was reported to be normal in these
animals.14 As previously reported by Janssen et al23, changes in
emptying rate (the meal we used has a half-emptying time of 80–
140 min) are unlikely to influence the accommodation since this
Figure 6 Western blot analysis of neuronal isoform of nitric oxide synthase (nNOS) and inducible isoform of nitric oxide synthase (iNOS)
expression. Protein expression in muscular tissue of the gastric fundus was quantified by western blot analysis and compared between control (black
bar) and BioBreeding diabetes-prone (BB-DP) (white bar) animals. For nNOS, this was done for all ages: (A) 30, (B) 70 and (C and D) 220 days. For
iNOS, this was done for age 220 days (E and F). (G and H) Representative blots. The total amount of nNOS and iNOS protein was normalised to the
PGP9.5 protein and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Protein fold change was determined relative to the mean value of the
control group. **p<0.01.
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was measured in a short time period of only 20 min. These obser-
vations confirm that the normoglycaemic BB-DP rat can be consid-
ered a spontaneous animal model of inflammation-related
impaired gastric accommodation and provides an attractive model
for further mechanistic and therapeutic studies. We were, however,
not able to find a significant direct linear correlation between
changes in inflammation and alterations in gastric accommodation.
This can probably be explained by the fact that multiple control
factors are integrated in the change in gastric accommodation as
measured by the IGP technique.
Similar to previous observations, nitrergic function was also
disturbed in hyperglycaemic animals compared with control
rats. The underlying pathophysiology in BB-DP rats is likely to
be different from those observed in the gastric fundus of hyper-
glycaemic BB rats, where metabolic dysfunction is more likely to
be the key mechanism.20
Increased intestinal permeability and low-grade inflammation
have been found in patients suffering from functional GI disor-
ders.37 We described earlier that BB-DP rats have an increased
intestinal permeability that precedes mucosal inflammation, which
is followed by loss of nitrergic nerve function.22 These data
suggest that increased permeability promotes local inflammation
that may progress transmurally and affect nitrergic nerve function.
Although these findings are in the small intestine, previous data
showed that gastric permeability was also increased in the BB rat
model prior to the development of diabetes.38 This suggests that
an increased permeability of the stomach is a potential trigger that
may lead to low-grade inflammation and loss of nitrergic neurons.
However, this aspect is beyond the scope of the current study.
In summary, although an impaired nitrergic function at the
level of the intestine and the antrum was previously observed in
hyperglycaemic BB rats, we are the first to report that normogly-
caemic BB-DP rats also develop impaired nitrergic motor
control at the level of the myenteric plexus of the gastric
fundus. This underlies the impaired gastric accommodation that
was observed in the same animals. The precipitating trigger for
these alterations seems to be low-grade inflammation, accom-
panied by an increase of mast cells and followed by decreased
nNOS expression. These findings are reminiscent of previous
observations in patients with postinfectious FD with impaired
accommodation where an ongoing low-grade inflammation was
also suggested.9 11 Our findings identify the BB-DP BB rat the
first and promising spontaneous animal model for the study of
inflammation-induced gastric motor dysfunction.
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